Therapeutic equivalence codes from the FDA tell pharmacists which generic drugs can be safely swapped for brand-name versions. Learn how A and B codes work, why they matter, and what’s changing in 2025.
Category: Medicine and Pharmaceuticals - Page 2
Barcode scanning in pharmacies cuts medication errors by up to 93% by verifying the right patient, drug, dose, route, and time. Learn how it works, where it fails, and why it’s still the gold standard for safety.
The Hatch-Waxman Amendments of 1984 created the modern generic drug industry by letting companies approve cheaper versions faster, while giving brand-name makers extra patent time. Today, 90% of U.S. prescriptions are generic - saving billions annually.
Understand the difference between single-source and multi-source drugs to save money and avoid confusion. Learn how generics work, why prices vary, and what to ask your pharmacist.
Learn when in vivo and in vitro bioequivalence testing are used for generic drugs. Understand FDA requirements, cost differences, and which method works best for different drug types.
Nasal congestion from overusing decongestant sprays is common and reversible. Learn how to break the cycle with proven methods like corticosteroids and saline rinses - and avoid relapse.
Pill packs and blister packaging help seniors take medications correctly by organizing doses by day and time. These systems reduce errors, improve adherence, and give independence to older adults managing multiple prescriptions.
Understand when to report serious vs non-serious adverse events in clinical trials. Learn the FDA and ICH criteria, reporting timelines, common mistakes, and how to avoid costly errors in safety monitoring.
Methadone can dangerously prolong the heart's QT interval, especially when combined with other medications. This article explains how the interaction works, who's at highest risk, and what steps can prevent sudden cardiac death.
Learn how generic drug substitution laws vary across all 50 U.S. states and D.C., including mandatory rules, patient consent, biosimilar requirements, and real-world impacts on patients and pharmacists.